MicroRNAs Modulate Oxidative Stress in Hypertension through PARP-1 Regulation

Douglas F Dluzen1, Yoonseo Kim1, Paul Bastian2

  • 1Laboratory of Epidemiology and Population Science, National Institute on Aging, National Institutes of Health, 251 Bayview Boulevard, Baltimore, MD 21224, USA.

Insights

Poly-(ADP-ribose) polymerase 1 (PARP-1) is upregulated in African American women with hypertension. Specific microRNAs (miRNAs) regulate PARP-1, impacting DNA damage and cell survival, offering insights into hypertension disparities.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiovascular Research

Background:

  • Oxidative stress contributes to aging, age-related diseases, and hypertension.
  • Previous studies reported differential mRNA and microRNA (miRNA) expression in women with hypertension based on race.
  • Poly-(ADP-ribose) polymerase 1 (PARP-1), a DNA damage sensor, is implicated in cellular processes and disease.

Purpose of the Study:

  • To investigate the role of PARP-1 in hypertension, particularly in African American women.
  • To identify specific miRNAs that regulate PARP-1 expression.
  • To explore the functional consequences of miRNA-mediated PARP-1 regulation on DNA damage and cell survival.

Main Methods:

  • Analysis of PARP-1 expression in African American women with hypertension.
  • Identification and validation of miRNAs targeting PARP1 using overexpression studies and luciferase reporter assays.
  • Assessment of DNA damage, cell survival, and colony formation following miRNA overexpression.

Main Results:

  • PARP-1 was found to be upregulated in African American women with hypertension.
  • miR-103a-2-5p and miR-585-5p were identified as regulators of PARP1, binding within its coding region.
  • Overexpression of these miRNAs led to increased DNA damage and reduced cell survival and colony formation.

Conclusions:

  • PARP-1 plays a significant role in regulating oxidative DNA damage in hypertension.
  • miR-103a-2-5p and miR-585-5p are novel regulators of PARP-1 expression.
  • These findings may elucidate mechanisms underlying hypertension health disparities.

Related Concept Videos

Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
7.7K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.2K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
3.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.6K